Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The physiological iron transport and utilization system is a complex network of proteins and pathways responsible for maintaining iron homeostasis, which is essential for erythropoiesis, DNA synthesis, and cellular respiration. Key components include transferrin for plasma transport, the transferrin receptor for cellular uptake, ferritin for intracellular storage, and ferroportin for cellular export. The system is tightly regulated by the hormone hepcidin, which controls iron entry into the plasma from the diet and storage sites. Dysregulation of this system leads to significant clinical conditions, such as iron deficiency anemia or iron overload disorders like hereditary hemochromatosis. Pharmacological interventions include iron salts for deficiency, iron chelators for overload, and emerging hepcidin mimetics or inhibitors to treat disorders of iron distribution.
Drugs targeting this system act by supplementing elemental iron, chelating excess iron to prevent toxicity, or modulating regulatory hormones like hepcidin to control iron absorption and distribution.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Physiological iron transport and utilization system.